Pharma

Company generated €78m in turnover from two sites in the Republic

Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily the most significant

Agreed statement between the EU and US gives a firm commitment to cap pharma tariffs at 15%, while some parts of the sector may be excluded altogether

Government to push for more sectors to enjoy tariff ‘carve outs’ in EU-US agreement

Perfection was priced in, anything less provoked panic as shares were hit with worst one-day drop in 25 years

Joint US-EU statement on details of new tariff regime has yet to emerge three weeks after deal was agreed

Nutriband is on track to become a billion-dollar business, while the presidency is a ceremonial role

A spokesman for the multi-millionaire says he expected to have the backing of at least four local authorities

Threat of additional pharma tariffs just a week after 15% rates was agreed risk undermining support for EU trade deal

The big tech and pharma multinationals are trying to reach accommodations with Trump, with vital implications for us

‘Trump’s trade war is good for Irish beef’ but nervousness pervades the dairy, pharmaceutical and computer chip sectors

Weight loss comes in at lower end of expectations and triggers stock boost for rival Novo Nordisk

Micheál Martin says Ireland has added value to the global reach of Big Pharma companies that have operations in the State

Pharmaceuticals account for the bulk of Irish exports to the US and any change, or even uncertainty, on tariffs poses major challenges

Novo Nordisk has now lost two-thirds of its value in little over a year

Towns such as Westport and Kinsale are anxiously waiting to see what happens next. They’re not alone

Pharma companies also volatile in wake of letters from US president to 17 of them demanding lower prices

Inside Business podcast with Ciarán Hancock

Pharmaceuticals and semiconductors accounted for the bulk of Ireland’s exports to the US in 2024

Pharmaceutical giants in Europe brace themselves for a tariffs fight that is likely still to come

Biggest plus is that it avoids an all-out fight between the EU and US

Companies in the early phases of scenario planning and hesitant to commit to major changes while negotiations remain unresolved

As the US president puts pressure on the EU and again threatens pharma tariffs, the costs of his project are slowly appearing

Pharma companies have been stockpiling in anticipation of tariffs, which Trump says will be in place next month.

Additional threat certain to alarm Government already working with EU to reduce impact of threatened 30% general tariff on exports to US

Brussels feels it has already offered a lot of concessions to the US in tariff talks, so what else can now be put on the table?

Import tariffs will cost US households $2,400 this year, Yale research estimates. Sooner or later, the pain will start to bite

What are the key concerns to look out for as the vital transatlantic trade talks come to a head?

When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies

The EU must decide whether to sign a trade deal with Trump which still leaves it open for the US to attack key sectors

US president says companies will be given about a year ‘to get their act together’ before tariffs are imposed

Whatever strategy the US adopts, there are serious risks to Government revenue from the sector after 2026

With a US-based parent company, it says US tariffs, market volatility and ‘slower economic growth or recession’ could hit business

The best-financed lobbyists in the United States are protecting the pharmaceutical sector, but that may change

Brussels will try to avoid all-out trade war with US, but faces agreeing tariffs deal tilted in Washington’s favour

ECB report says Irish pharma exports behind jump in EU exports in first quarter

CIF calls on Government to remove ‘roadblocks’ creating ‘persistent uncertainty in Ireland’s infrastructure pipeline’

Managing partner seeks to leverage AI as firm and clients grapple with uncertainty caused by Donald Trump’s tariffs

The art of the tariff deal may prove far more damaging to the US than Europe

Ireland has the opportunity to lead a new generation of European research by acting quickly to increase funding and supports